NCT07711678尚未招募不适用
A Pilot Study of Implantable Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 入组人数
- 10
- 试验地点
- 1
- 主要终点
- Response Based on the Apnea-Hypopnea Index With a ≥3% Oxygen Desaturation Criterion (AHI3)
研究概览
简要总结
The objective of this study is to evaluate the safety and preliminary effectiveness of an implantable hypoglossal nerve stimulation system for moderate-to-severe obstructive sleep apnea (OSA).
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Age 18 years or older, regardless of sex.
- •Moderate-to-severe obstructive sleep apnea confirmed by polysomnography, with an apnea-hypopnea index of 15 to 100 events per hour.
- •Prior failure of, intolerance to, or unwillingness to continue positive airway pressure therapy.
- •Body mass index ≤40 kg/m².
- •Able to communicate with the investigator, understand the study requirements, and provide written informed consent.
- •Willing and able to comply with study procedures and complete postoperative follow-up visits.
排除标准
- •Central and mixed apnea and hypopnea events account for more than 25% of the total apnea-hypopnea index.
- •Presence of obvious fixed upper airway obstruction or obstructive upper airway lesions, including but not limited to tumors or masses, polyps, scar stenosis, or severe nasal septal deviation involving the nasal cavity, nasopharynx, oropharynx, hypopharynx, or larynx, which, in the investigator's judgment, may affect device implantation, treatment effect, or evaluation of the primary effectiveness endpoint.
- •Abnormal hypoglossal nerve function; neurological or neuromuscular disease that may affect upper airway neuromuscular control or tongue movement; or clinically significant dysphagia.
- •Severe cardiopulmonary disease, including but not limited to chronic obstructive pulmonary disease, severe asthma, chronic respiratory failure, myocardial infarction, or severe arrhythmia.
- •Any disease or condition that precludes general anesthesia or may interfere with implantation of the hypoglossal nerve stimulation system.
- •Pregnant or lactating women, or women planning pregnancy during the study period.
- •Any condition that, in the investigator's judgment, makes the participant unsuitable for participation in this study.
- •Participation in another clinical trial within 4 weeks before signing informed consent.
- •Presence of an implanted active medical device that may interact with the investigational hypoglossal nerve stimulation system, affect treatment effectiveness, or compromise participant safety.
- •Unable or unwilling to discontinue other obstructive sleep apnea-related treatments during the study, except for the investigational hypoglossal nerve stimulation system manufactured by Beijing PINS Medical Co., Ltd.
结局指标
主要结局
Response Based on the Apnea-Hypopnea Index With a ≥3% Oxygen Desaturation Criterion (AHI3)
时间窗: 3 months after therapy activation
次要结局
- Investigator Equipment Satisfaction Evaluation(3 months after therapy activation)
- Malfunction Rates of External Devices and Accessories(3 months after therapy activation)
- Response Based on the Oxygen Desaturation Index With a ≥3% Oxygen Desaturation Criterion (ODI3)(3 months after therapy activation)
- Change in Percentage of Total Sleep Time With Oxygen Saturation Below 90%(3 months after therapy activation)
- Change in Epworth Sleepiness Scale (ESS) Score(3 months after therapy activation)
- Change in Functional Outcomes of Sleep Questionnaire-10 (FOSQ-10) Total Score(3 months after therapy activation)
- Participant Investigator Equipment Satisfaction Evaluation(3 months after therapy activation)
研究者
研究点 (1)
Loading locations...
相似试验
尚未招募
不适用
Assessment of the Effect of Hypoglossal Nerve Stimulation Therapy on Upper Airway Collapsibility During Drug-induced Sleep EndoscopyNCT07337239University Hospital, Antwerp21
尚未招募
2 期
Lingual Nerve Disruption to Augment Neoadjuvant Chemoimmunotherapy in Locally Advanced Tongue CancerNCT07346807Shanghai Zhongshan Hospital69
已完成
Unknown
XII Medical Hypoglossal Nerve Stimulation EvaluationA Technical Feasibility StudyObstructive Sleep Apnea (OSA)Respiratory - Sleep apnoeaACTRN12623000942651XII Medical, Inc.3
已完成
不适用
Targeted Hypoglossal Neurostimulation Study #3Obstructive Sleep ApneaNCT02263859ImThera Medical, Inc.138
已完成
不适用
Minimally Invasive Hypoglossal Nerve Stimulation Study (Lingual Study)Sleep Apnea, ObstructiveNCT03210142Medtronic Cardiac Rhythm and Heart Failure23